Cortical have an addressable annual opportunity of 50-200 million in US alone as reported in announcements and from what I have read have a very good product that integrates with exisiting hardware systems in hospitals.
Say they are able to unlock 50 million, on the lower end of expectations, well BPH have 18% and working off a price to earnings of 8x it would be worth 72M market cap or 12c of BPH price. Let alone the sales it expects to get from approved countries like Korea and Australia.
What isn't taken into account is any further costs to enable mass distribution. Which could come with a distribution agreement and margin %
Advent takes out insurance with new NOPTA application, page-280
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.67M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $28.50K | 2.371M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1058624 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 1340704 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BPH (ASX) Chart |